Salimi Elias, Assar Shirin, Rashidi Mahsa, Mohamadzadeh Dena
Clinical Research Development Centre, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Mediterr J Rheumatol. 2024 Oct 22;36(1):69-72. doi: 10.31138/mjr.160724.eoa. eCollection 2025 Mar.
While ultraviolet light is a well-known environmental trigger of Systemic lupus erythematosus (SLE), it is unknown whether other spectra of light including infrared could affect SLE activity. This study aimed to evaluate the effect of laser hair removal which emits red and infrared light on the activity of SLE.
20 patients with SLE were enrolled. Six monthly sessions of laser hair removal with Alexandrite laser were done. Demographic and clinical data were recorded. SLE disease activity index (SLEDAI-2K), serum levels of Anti-ds-DNA, C3, C4, and CH50 complement levels, and white blood cell and platelet counts were measured before and after the laser course to investigate the activity of SLE.
Most of the participants were female (90%) with a mean age of 32.65. Prednisolone was the most commonly used medication (95%) followed by hydroxychloroquine (90%). The most common skin types according to Fitzpatrick's classification were types II and III. We found no significant differences between the SLEDAI-2K score, and serum level of Anti-ds-DNA, C4, and C3 before and after the laser hair removal.
Laser hair removal is safe and does not affect the activity of SLE and might not induce disease exacerbation.
虽然紫外线是系统性红斑狼疮(SLE)一种众所周知的环境触发因素,但包括红外线在内的其他光谱是否会影响SLE活动尚不清楚。本研究旨在评估发射红色和红外线的激光脱毛对SLE活动的影响。
招募了20例SLE患者。使用翠绿宝石激光进行了6个月的激光脱毛治疗。记录人口统计学和临床数据。在激光治疗疗程前后测量SLE疾病活动指数(SLEDAI-2K)、抗双链DNA血清水平、C3、C4和CH50补体水平以及白细胞和血小板计数,以研究SLE的活动情况。
大多数参与者为女性(90%),平均年龄为32.65岁。泼尼松龙是最常用的药物(95%),其次是羟氯喹(90%)。根据菲茨帕特里克分类法,最常见的皮肤类型为II型和III型。我们发现激光脱毛前后SLEDAI-2K评分、抗双链DNA血清水平、C4和C3之间没有显著差异。
激光脱毛是安全的,不会影响SLE的活动,也可能不会导致疾病加重。